scholarly journals Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

2020 ◽  
Vol Volume 14 ◽  
pp. 2337-2345
Author(s):  
Tracey Weiss ◽  
Richard D Carr ◽  
Sampriti Pal ◽  
Lingfeng Yang ◽  
Baanie Sawhney ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
United States ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
The United States ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

scholarly journals Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain

2021 ◽  
Author(s):  
Kirsi Norrbacka ◽  
Antoni Sicras-Mainar ◽  
Jeremie Lebrec ◽  
Esther Artime ◽  
Silvia Díaz ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

scholarly journals PDB119 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN TYPE 2 DIABETES MELLITUS (T2DM): DATA FROM A REAL WORLD STUDY IN SPAIN

2019 ◽  
Vol 22 ◽  
pp. S594
Author(s):  
K. Norrbacka ◽  
A. Sicras-Mainar ◽  
I. Hernández ◽  
S. Tofé-Povedano ◽  
S. Díaz Cerezo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States

2014 ◽  
Vol 31 (11) ◽  
pp. 1119-1133 ◽  
Author(s):  
Stephen S. Johnston ◽  
Hiep Nguyen ◽  
Eugene Felber ◽  
Katherine Cappell ◽  
James K. Nelson ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
United States ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Agonist ◽  
The United States ◽  
Agonist Therapy ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document